EPISODE · Nov 9, 2020 · 51 MIN
Vaccine in Sight, What Now for Stocks?
from Halftime Report · host CNBC
Pfizer’s Covid Vaccine shows to be more than 90% effective in clinical trials, Scott Wapner and the Investment Committee discuss the stunning news as the market soars to record highs. Is it time to buy the ‘reopening’ stocks and sell the high-flying ‘stay-at-home’ stocks? Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
Pfizer’s Covid Vaccine shows to be more than 90% effective in clinical trials, Scott Wapner and the Investment Committee discuss the stunning news as the market soars to record highs. Is it time to buy the ‘reopening’ stocks and sell the high-flying ‘stay-at-home’ stocks?
NOW PLAYING
Vaccine in Sight, What Now for Stocks?
No transcript for this episode yet
Similar Episodes
May 14, 2026 ·26m
May 13, 2026 ·33m
May 13, 2026 ·49m
May 13, 2026 ·33m